New drug KESONOTIDE™ enters human trials for multiple cancers
Disease control
Recruiting now
This study tests a new drug, KESONOTIDE™, in people with advanced solid tumors like prostate, breast, lung, ovarian, pancreatic, skin cancer, or glioblastoma. The main goal is to check if the drug is safe and tolerable, and to find the right dose. About 80 adults will take part i…
Phase: PHASE1, PHASE2 • Sponsor: Filamon LTD • Aim: Disease control
Last updated May 16, 2026 22:33 UTC